Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)
NCT ID: NCT00692887
Last Updated: 2009-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2008-06-30
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To investigate the Foresee PHP ability to asses treatment progression post treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization
NCT00358345
Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects
NCT00884637
Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)
NCT01073592
PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)
NCT00359008
Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)
NCT01336907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The OCT May be use as well to identify choroidal neovascularization (CNV). Comparison between the two methods will allow better understanding of both devices.
The Foresee PHP can use as an assessment tool for the progression and success of the treatment given to AMD lesions. Therefore, evaluation the size and the location of the treated lesions may serve as an additional tool.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Subjects diagnosed as new CNV or treated CNV
PHP - Preferential Hyperacuity Perimeter (Foresee)
computerized test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PHP - Preferential Hyperacuity Perimeter (Foresee)
computerized test
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects diagnosed as new CNV or treated CNV
* Age \>50 years
* VA with habitual correction \<20/160 in the study eye
* Ability to understand instructions
Exclusion Criteria
* Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy,
* Any non-macular related ocular surgery performed within 3 months prior to study entry in the target eye
* Patients diagnosed with geographic atrophy (GA)
* Participation in another study with the exclusion of AREDS study
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Notal Vision Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Notal Vision
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anat Loewenstein, Prof.
Role: PRINCIPAL_INVESTIGATOR
Sorasky Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sorasky Medical center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
sponsor web site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHP-POST-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.